Literature DB >> 25989263

Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection.

M Matignon1,2,3, A Aissat4, F Canoui-Poitrine5,6, C Grondin2,3, C Pilon2,3, D Desvaux2,7, D Saadoun8,9, Q Barathon2,3, M Garrido9, V Audard1,2,3, P Rémy1,2,3, P Lang1,2, J Cohen2,3, P Grimbert1,2,3.   

Abstract

Although renal transplantation using expanded criteria donors has become a common practice, immune responses related to immunosenescence in those kidney allografts have not been studied yet in humans. We performed a retrospective molecular analysis of the T cell immune response in 43 kidney biopsies from patients with acute T cell-mediated rejection including 25 from recipients engrafted with a kidney from expanded criteria donor and 18 from recipients grafted with optimal kidney allograft. The clinical, transplant and acute T cell-mediated rejection characteristics of both groups were similar at baseline. The expression of RORγt, Il-17 and T-bet mRNA was significantly higher in the elderly than in the optimal group (p = 0.02, p = 0.036, and p = 0.01, respectively). Foxp3 mRNA levels were significantly higher in elderly patients experiencing successful acute T cell-mediated rejection reversal (p = 0.03). The presence of IL-17 mRNA was strongly associated with nonsuccessful reversal in elderly patients (p = 0.008). Patients with mRNA IL17 expression detection and low mRNA Foxp3 expression experienced significantly more treatment failure (87.5%) than patients with no mRNA IL17 expression and/or high mRNA Foxp3 expression (26.7%; p = 0.017). Our study suggests that the Th17 pathway is involved in pathogenesis and prognosis of acute T cell-mediated rejection in recipients of expanded criteria allograft. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Biomarker; donors and donation: extended criteria; molecular biology: mRNA/mRNA expression; rejection: T cell-mediated (TCMR)

Mesh:

Substances:

Year:  2015        PMID: 25989263     DOI: 10.1111/ajt.13304

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

1.  NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain.

Authors:  Mao Li; Srinivasa Rao Boddeda; Bo Chen; Qiang Zeng; Trenton R Schoeb; Victoria M Velazquez; Masako Shimamura
Journal:  Am J Transplant       Date:  2018-05-07       Impact factor: 8.086

2.  Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.

Authors:  Simon Ville; Nicolas Poirier; Julien Branchereau; Vianney Charpy; Sabrina Pengam; Véronique Nerriere-Daguin; Stéphanie Le Bas-Bernardet; Flora Coulon; Caroline Mary; Alexis Chenouard; Jeremy Hervouet; David Minault; Steven Nedellec; Karine Renaudin; Bernard Vanhove; Gilles Blancho
Journal:  J Am Soc Nephrol       Date:  2016-05-09       Impact factor: 10.121

3.  Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.

Authors:  M B Ezzelarab; D Raich-Regue; L Lu; A F Zahorchak; A Perez-Gutierrez; A Humar; M Wijkstrom; M Minervini; R W Wiseman; D K C Cooper; A E Morelli; A W Thomson
Journal:  Am J Transplant       Date:  2017-02-02       Impact factor: 8.086

Review 4.  Environmental Exposures-The Missing Link in Immune Responses After Transplantation.

Authors:  W Julliard; L A Owens; C A O'Driscoll; J H Fechner; J D Mezrich
Journal:  Am J Transplant       Date:  2016-01-30       Impact factor: 8.086

5.  Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation.

Authors:  Kevin Louis; Paul Fadakar; Camila Macedo; Masaki Yamada; Michelle Lucas; Xinyan Gu; Adriana Zeevi; Parmjeet Randhawa; Carmen Lefaucheur; Diana Metes
Journal:  Kidney Int       Date:  2022-01-26       Impact factor: 18.998

6.  IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients.

Authors:  Mahmoud Sadeghi; Imad Lahdou; Gerhard Opelz; Arianeb Mehrabi; Martin Zeier; Paul Schnitzler; Volker Daniel
Journal:  BMC Immunol       Date:  2016-10-03       Impact factor: 3.615

7.  Specific expression of heme oxygenase-1 by myeloid cells modulates renal ischemia-reperfusion injury.

Authors:  Maxime Rossi; Antoine Thierry; Sandrine Delbauve; Nicolas Preyat; Miguel P Soares; Thierry Roumeguère; Oberdan Leo; Véronique Flamand; Alain Le Moine; Jean-Michel Hougardy
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

8.  Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.

Authors:  Caroline Pilon; Jeremy Bigot; Cynthia Grondin; Allan Thiolat; Philippe Lang; José L Cohen; Philippe Grimbert; Marie Matignon
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

9.  Histopathological analysis of infiltrating T cell subsets in acute T cell-mediated rejection in the kidney transplant.

Authors:  Francisco Salcido-Ochoa; Susan Swee-Shan Hue; Siyu Peng; Zhaoxiang Fan; Reiko Lixiang Li; Jabed Iqbal; John Carson Allen; Alwin Hwai Liang Loh
Journal:  World J Transplant       Date:  2017-08-24

10.  Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes.

Authors:  Amar Singh; Sabarinathan Ramachandran; Melanie L Graham; Saeed Daneshmandi; David Heller; Wilma Lucia Suarez-Pinzon; Appakalai N Balamurugan; Jeffrey D Ansite; Joshua J Wilhelm; Amy Yang; Ying Zhang; Nagendra P Palani; Juan E Abrahante; Christopher Burlak; Stephen D Miller; Xunrong Luo; Bernhard J Hering
Journal:  Nat Commun       Date:  2019-08-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.